Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals)
split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)
Centralised EU authorisationActive
Marketing holder: GlaxoSmithKline Biologicals S.A.
Verified 2026-10-09 · EMA
- Source: EMA
Composition
- split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)
Registration
- Registration number
- EMEA/H/C/001206
- Registration status
- Active
- ATC code
- J07BB02
Sources
- product · EMA · EMEA/H/C/001206 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/001206 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/001206 · Verified 2026-10-09